New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Post published:April 15, 2021 Post category:Press Release
Albert Labs Appoints Mackie Research As Lead Agent For Private Placement Of Proceeds Up To $4 Million Pre-RTO Post published:April 14, 2021 Post category:Press Release
Red Light Holland Enters into Letter of Intent to Acquire Controlling Stake in Happy Caps Mushroom Farm based in Halifax, Nova Scotia Post published:April 13, 2021 Post category:Press Release
Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening Post published:April 13, 2021 Post category:Press Release
Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications Post published:April 13, 2021 Post category:Press Release
Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board Post published:April 13, 2021 Post category:Press Release
PsyBio Therapeutics Announces Application to List on OTCQX Post published:April 13, 2021 Post category:Press Release
MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company’s Psychedelic Digital Therapeutics Technology Platform Post published:April 13, 2021 Post category:Press Release
Awakn launches Digital unit and signs agreement with the University of Exeter Post published:April 12, 2021 Post category:Press Release